BLAIR WILLIAM & CO/IL - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 116 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.6%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$442,000
-66.1%
25,150
-81.3%
0.00%
-60.0%
Q2 2021$1,303,000
-51.7%
134,340
-46.5%
0.01%
-50.0%
Q1 2021$2,696,000
-37.1%
251,054
-13.8%
0.01%
-37.5%
Q4 2020$4,283,000
-11.0%
291,187
-14.0%
0.02%
-20.0%
Q3 2020$4,814,000
+153.6%
338,770
+44.4%
0.02%
+122.2%
Q2 2020$1,898,000234,5550.01%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders